Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Magnesium Sulfate on Periventricular Leukomalacia in Preterm Neonates
NCT00120588Phase 4Completed
- Sponsor
- Rouen University Hospital
- Start
- Jul 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in periventricular leukomalacia (PVL), brain ischemia and intracranial hemorrhage (ICH) comparing Magnesium Sulfate with Placebo (2 arms). Primary endpoints: Death up to discharge of hospital, Severe white matter injury and 1 more. Started Jul 1997; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
periventricular leukomalacia (PVL)brain ischemiaintracranial hemorrhage (ICH)
Beyond the preview
Go deeper on NCT00120588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00120588.